These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 16332944

  • 1. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE, King JH.
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [Abstract] [Full Text] [Related]

  • 2. Aminoglycoside pharmacokinetic parameters in neurocritical care patients undergoing induced hypothermia.
    Mercer JM, Neyens RR.
    Pharmacotherapy; 2010 Jul; 30(7):654-60. PubMed ID: 20575630
    [Abstract] [Full Text] [Related]

  • 3. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA.
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [Abstract] [Full Text] [Related]

  • 4. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS, Capitano B, Bies R, Bigos KL, Smith R, Lee H.
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [Abstract] [Full Text] [Related]

  • 5. Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate?
    O'Shea S, Duffull S, Johnson DW.
    Semin Dial; 2009 Dec; 22(3):225-30. PubMed ID: 19386073
    [Abstract] [Full Text] [Related]

  • 6. Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.
    Goetz DR, Pancorbo S, Hoag S, Bloom P.
    Am J Hosp Pharm; 1980 Aug; 37(8):1077-83. PubMed ID: 7405935
    [Abstract] [Full Text] [Related]

  • 7. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
    Mann HJ, Wittbrodt ET, Baghaie AA, Cerra FB.
    Pharmacotherapy; 1998 Aug; 18(2):371-8. PubMed ID: 9545157
    [Abstract] [Full Text] [Related]

  • 8. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T, Swoboda S, Zarfeshenfard F, Trentler B, Lipsett PA.
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [Abstract] [Full Text] [Related]

  • 9. Carbenicillin inactivation of aminoglycosides in patients with severe renal failure.
    Weibert R, Keane W, Shapiro F.
    Trans Am Soc Artif Intern Organs; 1976 Jul; 22():439-43. PubMed ID: 951863
    [Abstract] [Full Text] [Related]

  • 10. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 2000 Jul; 16():280-4. PubMed ID: 11045311
    [Abstract] [Full Text] [Related]

  • 11. Disease severity adversely affects delivery of dialysis in acute renal failure.
    Schiffl H.
    Nephron Clin Pract; 2007 Jul; 107(4):c163-9. PubMed ID: 17975323
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB, Dowell JA, Pratt RD.
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [Abstract] [Full Text] [Related]

  • 13. Development of a semimechanistic model to describe the pharmacokinetics of gentamicin in patients receiving hemodialysis.
    Dang L, Duffull S.
    J Clin Pharmacol; 2006 Jun; 46(6):662-73. PubMed ID: 16707413
    [Abstract] [Full Text] [Related]

  • 14. Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis.
    Mann HJ, Fuhs DW, Awang R, Ndemo FA, Cerra FB.
    Clin Pharm; 1987 Feb; 6(2):148-53. PubMed ID: 3665367
    [Abstract] [Full Text] [Related]

  • 15. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Bacopoulou F, Markantonis SL, Pavlou E, Adamidou M.
    J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis.
    Tsaganos T, Kouki P, Digenis P, Giamarellou H, Giamarellos-Bourboulis EJ, Kanellakopoulou K.
    Int J Antimicrob Agents; 2008 Jul; 32(1):46-9. PubMed ID: 18534825
    [Abstract] [Full Text] [Related]

  • 17. Aminoglycoside elimination in extended duration hemodialysis.
    Dager WE.
    Ann Pharmacother; 2006 Apr; 40(4):783-4. PubMed ID: 16569808
    [No Abstract] [Full Text] [Related]

  • 18. Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis.
    Rauf AA, Long KH, Gajic O, Anderson SS, Swaminathan L, Albright RC.
    J Intensive Care Med; 2008 Apr; 23(3):195-203. PubMed ID: 18474503
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.
    Fuhrmann V, Schenk P, Jaeger W, Ahmed S, Thalhammer F.
    J Antimicrob Chemother; 2004 Oct; 54(4):780-4. PubMed ID: 15347636
    [Abstract] [Full Text] [Related]

  • 20. Teicoplanin pharmacokinetics and dosage recommendations in chronic hemodialysis patients and in patients undergoing continuous veno-venous hemodialysis.
    Wolter K, Claus M, Wagner K, Fritschka E.
    Clin Nephrol; 1994 Dec; 42(6):389-97. PubMed ID: 7882603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.